These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 282445)

  • 21. Controlled, double-blind, comparative studies of disease modifying anti-rheumatic drugs in the treatment of patients with rheumatoid arthritis. A review.
    Halberg P
    Dan Med Bull; 1984 Oct; 31(5):391-402. PubMed ID: 6391848
    [No Abstract]   [Full Text] [Related]  

  • 22. [Main anti-rheumatoidal drugs--the place of levamisole among them].
    Skotnicki AB; Hoszowska B; Blicharski J; Bucka J
    Przegl Lek; 1983; 40(3):335-43. PubMed ID: 6346401
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chlorbutin, azathioprine, D-penicillamine and levamisole (decaris) in the treatment of patients with rheumatoid arthritis. IV. Comparative evaluation of their effects on systemic (extra-articular) manifestations of the disease].
    Krel' AA; Kanevskaia MZ; Chichasova NV; Khamishon LZ; Nemchenov EN
    Ter Arkh; 1985; 57(8):44-52. PubMed ID: 3906995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of low dose levamisole and penicillamine in rheumatoid arthritis.
    Clemens LE; Ansell BM; Bernstein RM; Hall MA; McCauley D
    Aust N Z J Med; 1983 Dec; 13(6):578-82. PubMed ID: 6586147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The basic treatment of rheumatoid arthritis. Current trends].
    Suţeanu S; Manuchian M
    Med Interne; 1984; 22(4):241-51. PubMed ID: 6393302
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chlorbutin, azathioprine, D-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis. Comparative analysis of their effect on the indices of disease activity and progression].
    Krel' AA; Kanevskaia MZ; Rashchupkina ZP; Bolotin EV; Chichasova NV
    Ter Arkh; 1982; 54(6):82-92. PubMed ID: 7112429
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: bood review joint diseases and all the arthropathies.
    Rosenthal M
    J Rheumatol; 1980; 7(4):586-7. PubMed ID: 7420348
    [No Abstract]   [Full Text] [Related]  

  • 29. [The basic therapy of rheumatoid arthritis].
    Sigidin IaA
    Ter Arkh; 1988; 60(4):148-54. PubMed ID: 2899360
    [No Abstract]   [Full Text] [Related]  

  • 30. Neutrophil chemotaxis in rheumatoid arthritis. Effect of D-penicillamine, gold salts, and levamisole.
    Mowat AG
    Ann Rheum Dis; 1978 Feb; 37(1):1-8. PubMed ID: 629595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of the effects of levamisole on erythrocyte sedimentation rate, acute phase proteins, and anemia.
    Sany J
    J Rheumatol Suppl; 1978; 4():43-7. PubMed ID: 366142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Basic therapeutic drugs for rheumatoid arthritis].
    Franke M
    Med Klin; 1981 Oct; 76(21):63. PubMed ID: 7300788
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chlorbutin, azathioprine, d-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis patients. III. A comparative analysis of their effect on the morphological manifestations of synovitis based on puncture biopsy data].
    Shekhter AB; Krel' AA; Chichasova NV; Rashchupkina ZP
    Ter Arkh; 1984; 56(2):121-31. PubMed ID: 6710393
    [No Abstract]   [Full Text] [Related]  

  • 34. Rheumatoid arthritis: some personal considerations on treatment. Part II.
    Kean WF; Buchanan WW
    Br J Clin Pract; 1983 Feb; 37(2):45-52. PubMed ID: 6344897
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of rheumatoid arthritis by a single daily dose of levamisole. A comparative trial with gold salts].
    Ristori JM; Bussiere JL; Sauvezie B; Epifanie JL; Rampon S
    Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):57-62. PubMed ID: 6342114
    [No Abstract]   [Full Text] [Related]  

  • 36. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The drug spectrum in rheumatoid arthritis therapy].
    Fellinger K
    Acta Med Austriaca; 1975; 2(4):105-10. PubMed ID: 1224926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Basic therapy of rheumatic diseases].
    Trnavskiĭ K
    Vopr Revm; 1981; (3):69-70. PubMed ID: 7032069
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rheumatoid arthritis. Considerations on a rational therapeutic strategy].
    Tarocco RP; Faro G; Michelotti A; Sargiotto A
    Minerva Med; 1984 Feb; 75(8):363-74. PubMed ID: 6369174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.